PER 2.47% 7.9¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-40

  1. 4,124 Posts.
    lightbulb Created with Sketch. 1892
    Logzy you miss understand me I meant ethical will not get their hands on mine as shortfall
    Obvious they want to get all they can
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(2.47%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $129.2K 1.628M

Buyers (Bids)

No. Vol. Price($)
1 100000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 335302 4
View Market Depth
Last trade - 11.14am 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.